Literature DB >> 20187354

[Evaluation of correlations between cognitive performances and clinical dimensions of schizophrenia].

Ines Johnson1, Olfa Ben Azouz, Oussama Kebir, Lamia Dellagi, Isabelle Amado, Karim Tabbane.   

Abstract

BACKGROUND: Schizophrenia is characterised by positive and negative symptoms as well as thought disorders and disorganised behaviour. Multiple cognitive deficits within the areas of memory, attention and executive functions are also associated with schizophrenia. Aim of the study was to proceed to a study of correlations between clinical dimensions of schizophrenia and cognitive functions.
METHODS: The authors recruited 105 patients suffering from schizophrenia spectrum disorders (DSM IV criteria). The patients were clinically stabilised, showing no depressive state at the time of the study, with no organic brain disorders and no history of drug intake. They were clinically evaluated using the PANSS and the Calgary Depression Scale. A cognitive battery was also administered.
RESULTS: Positive dimension of schizophrenia was shown to be independent from any cognitive function. Disorganisation was negatively correlated to attention, working memory, long-term verbal memory and executive functions. Negative dimension was negatively correlated with working memory and executive functions.
CONCLUSION: Cognition wasn't correlated to the positive dimension of schizophrenia whereas it was correlated to the negative and to the disorganisation dimension of the disease. This is probably due to overlapping of concepts.

Entities:  

Mesh:

Year:  2009        PMID: 20187354

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  3 in total

1.  Effects of modified electroconvulsive therapy on the cognitive function and blood parameters in female patients with schizophrenia.

Authors:  Yansheng Jiang; Hongxing Zhang; Zifan Wang; Ling Zhao; Luxian Lv
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway.

Authors:  Mao-Sheng Fang; Xing Li; Hong Qian; Kuan Zeng; Meng Ye; Yong-Jie Zhou; Hui Li; Xiao-Chuan Wang; Yi Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

3.  The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors.

Authors:  Shengyun Chen; Yaxi Liu; Dennis Liu; Guican Zhang; Xiaoli Wu
Journal:  Schizophr Res Cogn       Date:  2021-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.